/index.html English News Release,Information,Latest News. /news/2024/news202490.html ������'s news release ������ Announces Completion of Cancellation of Treasury Shares is posted. 2024-11-29T15:30:00+09:00 /news/2024/news202489.html ������'s news release “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in South Korea is posted. 2024-11-28T08:30:00+09:00 /news/2024/news202488.html ������'s news release EISAI SIGNS RESEARCH COLLABORATION AGREEMENT WITH THE NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY TO INITIATE APOLIPOPROTEIN E GENETIC TESTING IN THE “AD-DMT REGISTRY” IN JAPAN is posted. 2024-11-26T08:30:00+09:00 /hhc/activity/085.html ������'s latest news Recent hhc Activities “Online Exchange Program between Lymphatic Filariasis Patients from Ommi Village, India, and ������ Employees ー Feeling the Unspoken Emotions of Patients” is posted. 2024-11-21T09:02:55+09:00 /news/2024/news202487.html ������'s news release ROZEBALAMIN® FOR INJECTION 25 MG (MECOBALAMIN) FOR AMYOTROPHIC LATERAL SCLEROSIS LAUNCHED IN JAPAN is posted. 2024-11-20T08:30:10+09:00 /news/2024/news202486.html ������'s news release ANTICANCER AGENT “TASFYGO® TABLETS 35mg” (TASURGRATINIB SUCCINATE) LAUNCHED IN JAPAN FOR BILIARY TRACT CANCER WITH FGFR2 GENE FUSION OR REARRANGEMENTS is posted. 2024-11-20T08:30:00+09:00 /news/2024/news202485.html ������'s news release NATIONWIDE TV COMMERCIAL LAUNCHED IN JAPAN TO RAISE AWARENESS ABOUT MCI (MILD COGNITIVE IMPAIRMENT) is posted. 2024-11-15T08:30:00+09:00 /news/2024/news202484.html ������'s news release ������ Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease is posted. 2024-11-15T01:00:00+09:00 /ir/library/presentations/index.html ������'s latest news IR “Second Quarter Financial Results Briefing for the Fiscal Year Ending March 31, 2025 (Material, Webcast)” is posted. 2024-11-11T12:35:00+09:00 /ir/library/settlement/index.html ������'s latest news IR “Second Quarter Financial Report for the Fiscal Year Ending March 31, 2025” is posted. 2024-11-08T12:30:00+09:00 /news/2024/news202483.html ������'s news release ������’s Corporate Venture Capital Subsidiary, ������ Innovation, Inc., Selected for AMED’s ‘Strengthening Program for Pharmaceutical Startup Ecosystem’ is posted. 2024-11-05T08:30:00+09:00 /news/2024/news202482.html ������'s news release ������mpletes Rolling Submission to US FDA for LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status is posted. 2024-11-01T08:30:00+09:00 /news/2024/news202481.html ������'s news release ������ Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference is posted. 2024-10-31T08:30:00+09:00 /news/2024/news202480.html ������'s news release EISAI PRESENTS LATEST CLINICAL FINDINGS SUGGESTING INHIBITION OF TAU PROPAGATION BY ANTI-MTBR TAU ANTIBODY E2814 AT THE 17TH CLINICAL TRIALS ON ALZHEIMER'S DISEASE CONFERENCE (CTAD) is posted. 2024-10-31T08:30:00+09:00 /news/2024/news202479.html ������'s news release REVENUE OF LEQEMBI® (PRELIMINARY BASIS) is posted. 2024-10-30T19:45:00+09:00